Delcath Systems Stock Today
| DCTH Stock | USD 15.97 0.32 2.04% |
Performance15 of 100
| Odds Of DistressLess than 9
|
Delcath Systems is trading at 15.97 as of the 30th of January 2025. This is a 2.04 percent increase since the beginning of the trading day. The stock's open price was 15.65. Delcath Systems has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. The performance scores are derived for the period starting the 31st of December 2024 and ending today, the 30th of January 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 29th of May 2018 | Category Healthcare | Classification Health Care |
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York. Delcath Systems operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 36.2 M outstanding shares of which 937.12 K shares are currently shorted by private and institutional investors with about 5.26 trading days to cover. More on Delcath Systems
Moving together with Delcath Stock
Moving against Delcath Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Delcath Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsDelcath Systems can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Delcath Systems' financial leverage. It provides some insight into what part of Delcath Systems' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Delcath Systems (DCTH) is traded on NASDAQ Exchange in USA. It is located in 1633 Broadway, New York, NY, United States, 10019 and employs 76 people. Delcath Systems is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 566.53 M. Delcath Systems conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 36.2 M outstanding shares of which 937.12 K shares are currently shorted by private and institutional investors with about 5.26 trading days to cover.
Delcath Systems currently holds about 10.2 M in cash with (31.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.19.
Check Delcath Systems Probability Of Bankruptcy
Ownership AllocationDelcath Systems holds a total of 36.2 Million outstanding shares. 30% of Delcath Systems outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Delcath Ownership Details
Delcath Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Citadel Advisors Llc | 2024-09-30 | 154 K | |
| Kennedy Capital Management Inc | 2024-09-30 | 136.5 K | |
| Legato Capital Management Llc | 2024-09-30 | 115.5 K | |
| Morgan Stanley - Brokerage Accounts | 2024-09-30 | 106.5 K | |
| Ikarian Capital, Llc | 2024-09-30 | 100.4 K | |
| Blackrock Inc | 2024-09-30 | 99.2 K | |
| Marshall Wace Asset Management Ltd | 2024-09-30 | 90.9 K | |
| Principal Financial Group Inc | 2024-09-30 | 89.4 K | |
| Eam Investors, Llc | 2024-09-30 | 88.2 K | |
| Rosalind Advisors, Inc. | 2024-09-30 | 2.7 M | |
| Aigh Capital Management, Llc | 2024-09-30 | 1.8 M |
Delcath Systems Historical Income Statement
Delcath Stock Against Markets
Delcath Systems Corporate Management
| Robin Wagge | VP Associates | Profile | |
| Vojislav MD | Chief Officer | Profile | |
| MS MBA | CEO Director | Profile | |
| David Hoffman | Corporate Counsel | Profile | |
| MD MSc | Chief Officer | Profile | |
| John MS | Chief Officer | Profile | |
| Kevin Muir | VP Operations | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Delcath Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Delcath Stock please use our How to Invest in Delcath Systems guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Delcath Systems. If investors know Delcath will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Delcath Systems listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.17) | Revenue Per Share | Quarterly Revenue Growth 14.689 | Return On Assets | Return On Equity |
The market value of Delcath Systems is measured differently than its book value, which is the value of Delcath that is recorded on the company's balance sheet. Investors also form their own opinion of Delcath Systems' value that differs from its market value or its book value, called intrinsic value, which is Delcath Systems' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Delcath Systems' market value can be influenced by many factors that don't directly affect Delcath Systems' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Delcath Systems' value and its price as these two are different measures arrived at by different means. Investors typically determine if Delcath Systems is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Delcath Systems' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.